Company Performance: Earnings reports, revenue growth, and profit margins directly impact investor sentiment and stock valuation.

Industry Trends: Overall health and growth prospects of the pharmaceutical sector influence the demand for and perceived value of the company's stock.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth can affect investment decisions and stock prices.

Regulatory Environment: Changes in government regulations, drug approvals, and healthcare policies can significantly impact the company's business and stock price.

Market Sentiment: General investor optimism or pessimism, often driven by global events or news, can affect stock prices regardless of company fundamentals.

Competitor Actions: Strategies and performance of rival pharmaceutical companies can influence market share and investor perceptions of the company's competitive position.

Global Events: Geopolitical events, pandemics, and global economic shifts can create volatility in the stock market and impact individual stock prices.

Investor Relations: How effectively the company communicates with investors and analysts influences confidence and ultimately, stock valuation.

Dividends: Dividend payouts can make the stock more attractive to income-seeking investors, potentially increasing demand and price.

Technological advancements: Developments in drug discovery and manufacturing can improve investor outlook and impact stock value.